{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:25Z","timestamp":1787017045939,"version":"build-2736575974"},"reference-count":87,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2026,5,25]]},"abstract":"<jats:p>Cardiovascular disease (CVD) accounts for a third of all deaths, making it the leading cause of mortality globally. Coronary microvascular dysfunction (CMD) has emerged as a prominent condition in menopausal women, leading to the development of chronic coronary syndrome (CCS). Despite the significant impact on this cohort, research gaps persist which can lead to shortcomings in the delivery of care to women. CMD is more prevalent in women than men and is linked to increased risk of major adverse cardiovascular events and mortality. During the menopausal transition, there is an acceleration in vascular ageing due to hormonal shift and metabolic changes, resulting in endothelial dysfunction. A large proportion of patients with Takotsubo syndrome and heart failure with preserved ejection fraction (HFpEF) are menopausal women with CMD; however, the underlying mechanisms are not fully understood. Limited evidence of the sex-specific pathophysiology of CMD has resulted in current clinical practice relying on evidence from male-dominant or mixed cohorts. This can lead to incorrect risk stratification, treatment side effects and poor prognosis in women. In addition, there is limited research on the efficacy of diagnostic techniques addressing the sex differences in those with CMD. Tailored diagnostic thresholds and models are essential to improve prognosis in women. Further evidence is needed to bridge these knowledge gaps to tackle the sex differences, achieve sex equality in CVD research and reduce the disproportionate burden of microvascular dysfunction in menopausal women.<\/jats:p>","DOI":"10.1136\/heartjnl-2026-328124","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:25:22Z","timestamp":1782149122000},"page":"heartjnl-2026-328124","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Coronary microvascular dysfunction in menopausal women"],"prefix":"10.1136","author":[{"given":"Denin","family":"Mathew","sequence":"first","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2975-6971","authenticated-orcid":false,"given":"Vijay","family":"Kunadian","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026062210251628000_heartjnl-2026-328124v1.1","unstructured":"World Health Organisation . Cardiovascular Diseases (CVDs). 2025."},{"key":"2026062210251628000_heartjnl-2026-328124v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2017.04.001"},{"key":"2026062210251628000_heartjnl-2026-328124v1.3","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.jacc.2024.04.028","article-title":"Addressing the Global Burden of Cardiovascular Disease in Women","volume":"83","author":"Vervoort","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026062210251628000_heartjnl-2026-328124v1.4","article-title":"Underrepresentation of women in cardiovascular trials- it is time to shatter this glass ceiling","volume":"13","author":"Tobb","year":"2022","journal-title":"Am Heart J Plus"},{"key":"2026062210251628000_heartjnl-2026-328124v1.5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.maturitas.2015.04.012","article-title":"Gynecardiology: Distinct patterns of ischemic heart disease in middle-aged women","volume":"81","author":"Elias-Smale","year":"2015","journal-title":"Maturitas"},{"key":"2026062210251628000_heartjnl-2026-328124v1.6","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-025-01310-1","article-title":"Examining the Disproportionate Burden of Microvascular Disease in Women","volume":"27","author":"O\u2019Hara","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"2026062210251628000_heartjnl-2026-328124v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.04.002"},{"key":"2026062210251628000_heartjnl-2026-328124v1.8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014954","article-title":"Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta-Analysis of Aggregate Data","volume":"9","author":"Gdowski","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026062210251628000_heartjnl-2026-328124v1.9","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.114198"},{"key":"2026062210251628000_heartjnl-2026-328124v1.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2244"},{"key":"2026062210251628000_heartjnl-2026-328124v1.11","article-title":"Vascular Aging across the Menopause Transition in Healthy Women","volume":"2014","author":"Moreau","year":"2014","journal-title":"Adv Vasc Med"},{"key":"2026062210251628000_heartjnl-2026-328124v1.12","doi-asserted-by":"crossref","first-page":"134226","DOI":"10.1016\/j.ijcard.2026.134226","article-title":"Microvascular vasomotor dysfunction is more prevalent in female versus epicardial vasomotor dysfunction in male ANOCA patients","volume":"450","author":"Woudstra","year":"2026","journal-title":"Int J Cardiol"},{"key":"2026062210251628000_heartjnl-2026-328124v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr331"},{"key":"2026062210251628000_heartjnl-2026-328124v1.14","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2024-324625","article-title":"Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies\u2019 consensus document","volume":"110","author":"Tayal","year":"2024","journal-title":"Heart"},{"key":"2026062210251628000_heartjnl-2026-328124v1.15","doi-asserted-by":"crossref","first-page":"1085914","DOI":"10.3389\/fcvm.2023.1085914","article-title":"Sex differences in contributors to coronary microvascular dysfunction","volume":"10","author":"Kwan","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026062210251628000_heartjnl-2026-328124v1.16","doi-asserted-by":"crossref","first-page":"108334","DOI":"10.1016\/j.diabres.2020.108334","article-title":"Sex differences in cardiovascular risk factors before and after the development of type 2 diabetes and risk for incident cardiovascular disease","volume":"166","author":"Bancks","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"2026062210251628000_heartjnl-2026-328124v1.17","doi-asserted-by":"crossref","first-page":"101667","DOI":"10.1016\/j.ijcha.2025.101667","article-title":"Sex differences in proteomics of cardiovascular disease \u2013 Results from the Yale-CMD registry","volume":"58","author":"Liu","year":"2025","journal-title":"IJC Heart Vasculature"},{"key":"2026062210251628000_heartjnl-2026-328124v1.18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12170-024-00738-5","article-title":"Coronary Microvascular Dysfunction in Women","volume":"18","author":"Gaignard","year":"2024","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"2026062210251628000_heartjnl-2026-328124v1.19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/oby.23289","article-title":"Body composition and cardiometabolic health across the menopause transition","volume":"30","author":"Marlatt","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"2026062210251628000_heartjnl-2026-328124v1.20","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.313622"},{"key":"2026062210251628000_heartjnl-2026-328124v1.21","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2013.202549"},{"key":"2026062210251628000_heartjnl-2026-328124v1.22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000001136","article-title":"Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies","volume":"25","author":"Hallajzadeh","year":"2018","journal-title":"Menopause"},{"key":"2026062210251628000_heartjnl-2026-328124v1.23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134435","article-title":"Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome","volume":"12","author":"Ou","year":"2023","journal-title":"J Clin Med"},{"key":"2026062210251628000_heartjnl-2026-328124v1.24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.maturitas.2011.03.012","article-title":"Endothelial biology in the post-menopausal obese woman","volume":"69","author":"Meadows","year":"2011","journal-title":"Maturitas"},{"key":"2026062210251628000_heartjnl-2026-328124v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2023.07.014"},{"key":"2026062210251628000_heartjnl-2026-328124v1.26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/GME.0000000000001755","article-title":"Abdominal visceral adipose tissue over the menopause transition and carotid atherosclerosis: the SWAN heart study","volume":"28","author":"Samargandy","year":"2021","journal-title":"Menopause"},{"key":"2026062210251628000_heartjnl-2026-328124v1.27","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1007\/s12350-021-02788-3","article-title":"Combining body mass index with waist circumference to assess coronary microvascular function in patients with non-obstructive coronary artery disease","volume":"29","author":"Wang","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"2026062210251628000_heartjnl-2026-328124v1.28","article-title":"Type 2 Diabetes Mellitus Prevalence and Associated Risk Factors in Postmenopausal Women","volume":"16","author":"Varalakshmi","year":"2024","journal-title":"Cureus"},{"key":"2026062210251628000_heartjnl-2026-328124v1.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2024.101132","article-title":"Sex differences and determinants of coronary microvascular function in asymptomatic adults with type 2 diabetes","volume":"27","author":"Yeo","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026062210251628000_heartjnl-2026-328124v1.30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011612","article-title":"Sex Differences in Culprit Plaque Characteristics Among Different Age Groups in Patients With Acute Coronary Syndromes","volume":"15","author":"Seegers","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"2026062210251628000_heartjnl-2026-328124v1.31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/GME.0000000000002292","article-title":"The association of menopause with cardiometabolic disease risk factors in low- and middle-income countries: a systematic review and meta-analyses","volume":"31","author":"Chikwati","year":"2024","journal-title":"Menopause"},{"key":"2026062210251628000_heartjnl-2026-328124v1.32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1139\/cjpp-2023-0414","article-title":"Coronary microvascular disease in women: epidemiology, mechanisms, evaluation, and treatment","volume":"102","author":"Steinberg","year":"2024","journal-title":"Can J Physiol Pharmacol"},{"key":"2026062210251628000_heartjnl-2026-328124v1.33","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jacc.2023.06.043","article-title":"Comprehensive Management of ANOCA, Part 1\u2014Definition, Patient Population, and Diagnosis","volume":"82","author":"Samuels","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026062210251628000_heartjnl-2026-328124v1.34","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.3390\/biomedicines10123010","article-title":"Pathophysiology and Outcomes of Endothelium Function in Coronary Microvascular Diseases: A Systematic Review of Randomized Controlled Trials and Multicenter Study","volume":"10","author":"Avtaar Singh","year":"2022","journal-title":"Biomedicines"},{"key":"2026062210251628000_heartjnl-2026-328124v1.35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2024.04.009","article-title":"An update on the mechanisms of Takotsubo syndrome: \u201cAt the end an acute coronary syndrome\u201d","volume":"191","author":"Crea","year":"2024","journal-title":"J Mol Cell Cardiol"},{"key":"2026062210251628000_heartjnl-2026-328124v1.36","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00442","article-title":"Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction","volume":"10","author":"Sickinghe","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026062210251628000_heartjnl-2026-328124v1.37","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy076"},{"key":"2026062210251628000_heartjnl-2026-328124v1.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406761"},{"key":"2026062210251628000_heartjnl-2026-328124v1.39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100983","article-title":"Coronary microvascular dysfunction and its role in heart failure with preserved ejection fraction for future prevention and treatment","volume":"22","author":"Bond","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"2026062210251628000_heartjnl-2026-328124v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.10.015"},{"key":"2026062210251628000_heartjnl-2026-328124v1.41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy531"},{"key":"2026062210251628000_heartjnl-2026-328124v1.42","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx721"},{"key":"2026062210251628000_heartjnl-2026-328124v1.43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004457","article-title":"Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial","volume":"11","author":"Lewis","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026062210251628000_heartjnl-2026-328124v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.03.024"},{"key":"2026062210251628000_heartjnl-2026-328124v1.45","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2631"},{"key":"2026062210251628000_heartjnl-2026-328124v1.46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"2026062210251628000_heartjnl-2026-328124v1.47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/978-3-319-77932-4_27","article-title":"Sex-Specific Physiology and Cardiovascular Disease","volume":"1065","author":"Shufelt","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"2026062210251628000_heartjnl-2026-328124v1.48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcha.2019.01.001","article-title":"A systematic review and meta-regression analysis to examine the \u2018timing hypothesis\u2019 of hormone replacement therapy on mortality, coronary heart disease, and stroke","volume":"22","author":"Nudy","year":"2019","journal-title":"IJC Heart Vasculature"},{"key":"2026062210251628000_heartjnl-2026-328124v1.49","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab042"},{"key":"2026062210251628000_heartjnl-2026-328124v1.50","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"2017","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026062210251628000_heartjnl-2026-328124v1.51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/20533691221104879","article-title":"Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause","volume":"28","author":"Hamoda","year":"2022","journal-title":"Post Reprod Health"},{"key":"2026062210251628000_heartjnl-2026-328124v1.52","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.amjmed.2024.04.035","article-title":"Coronary Microvascular Dysfunction: A Guide for Clinicians","volume":"137","author":"Smati","year":"2024","journal-title":"Am J Med"},{"key":"2026062210251628000_heartjnl-2026-328124v1.53","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-018-0710-5","article-title":"Microvascular Coronary Dysfunction-an Overview","volume":"20","author":"Naderi","year":"2018","journal-title":"Curr Atheroscler Rep"},{"key":"2026062210251628000_heartjnl-2026-328124v1.54","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092880","article-title":"Coronary Microvascular Dysfunction","volume":"9","author":"Vancheri","year":"2020","journal-title":"J Clin Med"},{"key":"2026062210251628000_heartjnl-2026-328124v1.55","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tem.2019.11.001","article-title":"Coronary Microvascular Dysfunction and Estrogen Receptor Signaling","volume":"31","author":"Tunc","year":"2020","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"2026062210251628000_heartjnl-2026-328124v1.56","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-320718"},{"key":"2026062210251628000_heartjnl-2026-328124v1.57","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jcin.2022.03.015","article-title":"Comparison of Doppler Flow Velocity and Thermodilution Derived Indexes of Coronary Physiology","volume":"15","author":"Demir","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2026062210251628000_heartjnl-2026-328124v1.58","doi-asserted-by":"crossref","unstructured":"Rahman H , Demir OM , Ryan M , et al . Optimal Use of Vasodilators for Diagnosis of Microvascular Angina in the Cardiac Catheterization Laboratory. Circ: Cardiovascular Interventions 2020;13. doi:10.1161\/CIRCINTERVENTIONS.120.009019","DOI":"10.1161\/CIRCINTERVENTIONS.120.009019"},{"key":"2026062210251628000_heartjnl-2026-328124v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.01.023"},{"key":"2026062210251628000_heartjnl-2026-328124v1.60","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae177"},{"key":"2026062210251628000_heartjnl-2026-328124v1.61","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.023266"},{"key":"2026062210251628000_heartjnl-2026-328124v1.62","doi-asserted-by":"crossref","unstructured":"Kay J , Dorbala S , Goyal A , et al . Influence of Sex on Risk Stratification With Stress Myocardial Perfusion Rb-82 Positron Emission Tomography: Results From the PET (Positron Emission Tomography) Prognosis Multicenter Registry. J Am Coll Cardiol 2013. doi:10.1016\/j.jacc.2013.06.017","DOI":"10.1016\/j.jacc.2013.06.017"},{"key":"2026062210251628000_heartjnl-2026-328124v1.63","article-title":"Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease","volume":"2","author":"Al-Badri","year":"2018","journal-title":"Curr Trends Clin Med Imaging"},{"key":"2026062210251628000_heartjnl-2026-328124v1.64","doi-asserted-by":"crossref","unstructured":"Thomson LEJ , Wei J , Agarwal M , et al . Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women\u2019s Ischemia Syndrome Evaluation. Circ Cardiovasc Imaging 2015;8. doi:10.1161\/CIRCIMAGING.114.002481","DOI":"10.1161\/CIRCIMAGING.114.002481"},{"key":"2026062210251628000_heartjnl-2026-328124v1.65","doi-asserted-by":"crossref","unstructured":"Koilpillai P , Aggarwal NR , Mulvagh SL . State of the Art in Noninvasive Imaging of Ischemic Heart Disease and Coronary Microvascular Dysfunction in Women: Indications, Performance, and Limitations. Curr Atheroscler Rep 2020;22. doi:10.1007\/s11883-020-00894-0","DOI":"10.1007\/s11883-020-00894-0"},{"key":"2026062210251628000_heartjnl-2026-328124v1.66","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s10554-023-02948-1","article-title":"The prognostic value of coronary flow reserve in patients with non-obstructive coronary artery disease and microvascular dysfunction: a systematic review and meta-analysis with focus on imaging modality and sex difference","volume":"39","author":"Jensen","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026062210251628000_heartjnl-2026-328124v1.67","doi-asserted-by":"crossref","unstructured":"Groepenhoff F , Klaassen RGM , Valstar GB , et al . Evaluation of non-invasive imaging parameters in coronary microvascular disease: a systematic review. BMC Med Imaging 2021;21. doi:10.1186\/s12880-020-00535-7","DOI":"10.1186\/s12880-020-00535-7"},{"key":"2026062210251628000_heartjnl-2026-328124v1.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.03.045"},{"key":"2026062210251628000_heartjnl-2026-328124v1.69","doi-asserted-by":"crossref","unstructured":"Tsj O , Rjj K , Jh C , et al . Myocardial blood flow and myocardial flow reserve values in 13N\u2013ammonia myocardial perfusion PET\/CT using a time-efficient protocol in patients without coronary artery disease. European J Hybrid Imaging 2018;2. doi:10.1186\/s41824-018-0029-z","DOI":"10.1186\/s41824-018-0029-z"},{"key":"2026062210251628000_heartjnl-2026-328124v1.70","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00202-4"},{"key":"2026062210251628000_heartjnl-2026-328124v1.71","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e3283406479"},{"key":"2026062210251628000_heartjnl-2026-328124v1.72","doi-asserted-by":"publisher","DOI":"10.1177\/2048872618764418"},{"key":"2026062210251628000_heartjnl-2026-328124v1.73","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead130"},{"key":"2026062210251628000_heartjnl-2026-328124v1.74","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1260427","article-title":"Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer\u2019s disease and dementia","volume":"15","author":"Nerattini","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"2026062210251628000_heartjnl-2026-328124v1.75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90084-y","article-title":"Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition","volume":"11","author":"Mosconi","year":"2021","journal-title":"Sci Rep"},{"key":"2026062210251628000_heartjnl-2026-328124v1.76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.14283\/jpad.2018.34","article-title":"Female Sex and Alzheimer\u2019s Risk: The Menopause Connection","volume":"5","author":"Scheyer","year":"2018","journal-title":"J Prev Alzheimers Dis"},{"key":"2026062210251628000_heartjnl-2026-328124v1.77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.maturitas.2022.10.012","article-title":"Cognitive decline and dementia in women after menopause: Prevention strategies","volume":"168","author":"Stefanowski","year":"2023","journal-title":"Maturitas"},{"key":"2026062210251628000_heartjnl-2026-328124v1.78","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000771"},{"key":"2026062210251628000_heartjnl-2026-328124v1.79","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2026.108884","article-title":"Age at natural menopause and cognitive aging in U.S. women: Educational attainment as a modifiable resilience factor","volume":"207","author":"Guo","year":"2026","journal-title":"Maturitas"},{"key":"2026062210251628000_heartjnl-2026-328124v1.80","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.20.2651"},{"key":"2026062210251628000_heartjnl-2026-328124v1.81","doi-asserted-by":"crossref","first-page":"104693","DOI":"10.1016\/j.phrs.2020.104693","article-title":"Postmenopausal hormone therapy and Alzheimer\u2019s disease, dementia, and Parkinson\u2019s disease: A systematic review and time-response meta-analysis","volume":"155","author":"Wu","year":"2020","journal-title":"Pharmacol Res"},{"key":"2026062210251628000_heartjnl-2026-328124v1.82","doi-asserted-by":"crossref","DOI":"10.1007\/s13669-024-00409-7","article-title":"Systematic Review and Meta-analysis of Menopause Hormone Therapy (MHT) and the Risk of Alzheimer\u2019s Disease and All-cause Dementia: Effects of MHT Characteristics, Location, and APOE-4 Status","volume":"14","author":"Mosconi","year":"2025","journal-title":"Curr Obstet Gynecol Rep"},{"key":"2026062210251628000_heartjnl-2026-328124v1.83","doi-asserted-by":"crossref","first-page":"100803","DOI":"10.1016\/j.lanhl.2025.100803","article-title":"Menopause hormone therapy and risk of mild cognitive impairment or dementia: a systematic review and meta-analysis","volume":"6","author":"Melville","year":"2025","journal-title":"Lancet Healthy Longev"},{"key":"2026062210251628000_heartjnl-2026-328124v1.84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41416-024-02590-1","article-title":"Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway","volume":"131","author":"St\u00f8er","year":"2024","journal-title":"Br J Cancer"},{"key":"2026062210251628000_heartjnl-2026-328124v1.85","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: Considerations for prevention and management","volume":"6","author":"LaVasseur","year":"2022","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"key":"2026062210251628000_heartjnl-2026-328124v1.86","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeag054","article-title":"Hormone replacement therapy and cardiovascular risk in postmenopausal women","volume":"6","author":"Blackburn","year":"2026","journal-title":"Eur Heart J Open"},{"key":"2026062210251628000_heartjnl-2026-328124v1.87","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/ehjqcco\/qcad007","article-title":"Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines","volume":"9","author":"Mas-Llado","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2026-328124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:25:31Z","timestamp":1782149131000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2026-328124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":87,"alternative-id":["10.1136\/heartjnl-2026-328124"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2026-328124","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}